Revolutionizing maternal and fetal health care with AI-driven insights for personalized prenatal management.
NeoGuard is a cutting-edge tool designed to revolutionize maternal and fetal care. Our dashboard leverages advanced AI models and data analytics to predict the risk of Fetal Growth Restriction (FGR) at birth, empowering healthcare professionals with insights to provide personalized and proactive care throughout the pregnancy journey.
NeoGuard combines ultrasound biometry, Doppler blood flow, and maternal serum biomarkers to deliver a high level of accuracy in FGR prediction, ensuring early detection and intervention. With comprehensive data analysis, NeoGuard enables clinicians to make evidence-based decisions to enhance patient outcomes.
Trusted by medical professionals, NeoGuard is poised to improve the health and safety of both mothers and their babies.
Accurately predict fetal growth restriction using advanced AI.
Utilizes key biomarkers for enhanced prediction accuracy.
Leverages data from leading institutions for early FGR detection.
Tailored care for better maternal and fetal outcomes.
We are excited to share our latest publication in Prenatal Diagnosis, highlighting our advancements in AI-driven fetal monitoring.
Read the Full PaperThis tool is for certified healthcare professionals and is provided 'as is' for informational purposes. Use it with independent professional judgment and at your own risk.
This work was supported in part by eDANA TED 1 Research Grant